These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 12433833)

  • 21. Multifarious molecular signaling cascades of cardiac hypertrophy: can the muddy waters be cleared?
    Balakumar P; Jagadeesh G
    Pharmacol Res; 2010 Nov; 62(5):365-83. PubMed ID: 20643208
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Disruption of integrin function in the murine myocardium leads to perinatal lethality, fibrosis, and abnormal cardiac performance.
    Keller RS; Shai SY; Babbitt CJ; Pham CG; Solaro RJ; Valencik ML; Loftus JC; Ross RS
    Am J Pathol; 2001 Mar; 158(3):1079-90. PubMed ID: 11238056
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Insulin signaling: a possible pathogenesis of cardiac hypertrophy.
    Yu W; Chen C; Fu Y; Wang X; Wang W
    Cardiovasc Ther; 2010 Apr; 28(2):101-5. PubMed ID: 20398099
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Calcium, calpains, and cardiac hypertrophy: a new link.
    Heidrich FM; Ehrlich BE
    Circ Res; 2009 Jan; 104(2):e19-20. PubMed ID: 19179660
    [No Abstract]   [Full Text] [Related]  

  • 25. Biochemical and cellular changes in cardiac hypertrophy.
    Rabinowitz M; Zak R
    Annu Rev Med; 1972; 23():245-62. PubMed ID: 4264782
    [No Abstract]   [Full Text] [Related]  

  • 26. Interaction of cardiac myocytes and non-myocytes in mechanical stress-induced hypertrophy.
    Yamazaki T; Shiojima I; Komuro I; Nagai R; Yazaki Y
    Herz; 1995 Apr; 20(2):109-17. PubMed ID: 7774862
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Calhex₂₃₁ Ameliorates Cardiac Hypertrophy by Inhibiting Cellular Autophagy in Vivo and in Vitro.
    Liu L; Wang C; Sun D; Jiang S; Li H; Zhang W; Zhao Y; Xi Y; Shi S; Lu F; Tian Y; Xu C; Wang L
    Cell Physiol Biochem; 2015; 36(4):1597-612. PubMed ID: 26159880
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tumor necrosis factor receptor-associated factor 3 is a positive regulator of pathological cardiac hypertrophy.
    Jiang X; Deng KQ; Luo Y; Jiang DS; Gao L; Zhang XF; Zhang P; Zhao GN; Zhu X; Li H
    Hypertension; 2015 Aug; 66(2):356-67. PubMed ID: 26034202
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CAMTA in cardiac hypertrophy.
    Schwartz RJ; Schneider MD
    Cell; 2006 May; 125(3):427-9. PubMed ID: 16678087
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thrombospondins in the transition from myocardial infarction to heart failure.
    Kirk JA; Cingolani OH
    J Mol Cell Cardiol; 2016 Jan; 90():102-10. PubMed ID: 26686988
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rosuvastatin improves myocardial hypertrophy after hemodynamic pressure overload via regulating the crosstalk of Nrf2/ARE and TGF-β/ smads pathways in rat heart.
    Wang P; Luo L; Shen Q; Shi G; Mohammed A; Ni S; Wu X
    Eur J Pharmacol; 2018 Feb; 820():173-182. PubMed ID: 29225188
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Suppression of calcium‑sensing receptor ameliorates cardiac hypertrophy through inhibition of autophagy.
    Liu L; Wang C; Lin Y; Xi Y; Li H; Shi S; Li H; Zhang W; Zhao Y; Tian Y; Xu C; Wang L
    Mol Med Rep; 2016 Jul; 14(1):111-20. PubMed ID: 27176663
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differences between pathological and physiological cardiac hypertrophy: novel therapeutic strategies to treat heart failure.
    McMullen JR; Jennings GL
    Clin Exp Pharmacol Physiol; 2007 Apr; 34(4):255-62. PubMed ID: 17324134
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The alpha1-adrenergic receptors in cardiac hypertrophy: signaling mechanisms and functional implications.
    Cotecchia S; Del Vescovo CD; Colella M; Caso S; Diviani D
    Cell Signal; 2015 Oct; 27(10):1984-93. PubMed ID: 26169957
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic factors in cardiac hypertrophy.
    Dorn GW; Hahn HS
    Ann N Y Acad Sci; 2004 May; 1015():225-37. PubMed ID: 15201163
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interplay between Cell-Surface Receptors and Extracellular Matrix in Skin.
    Kleiser S; Nyström A
    Biomolecules; 2020 Aug; 10(8):. PubMed ID: 32796709
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biomechanical Properties and Mechanobiology of Cardiac ECM.
    Nguyen-Truong M; Wang Z
    Adv Exp Med Biol; 2018; 1098():1-19. PubMed ID: 30238363
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Eccentric cardiac hypertrophy was induced by long-term intermittent hypoxia in rats.
    Chen LM; Kuo WW; Yang JJ; Wang SG; Yeh YL; Tsai FJ; Ho YJ; Chang MH; Huang CY; Lee SD
    Exp Physiol; 2007 Mar; 92(2):409-16. PubMed ID: 17185350
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MAP kinase- and Rho-dependent signals interact to regulate gene expression but not actin morphology in cardiac muscle cells.
    Thorburn J; Xu S; Thorburn A
    EMBO J; 1997 Apr; 16(8):1888-900. PubMed ID: 9155015
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Integrins and the myocardium.
    Ross RS; Borg TK
    Circ Res; 2001 Jun; 88(11):1112-9. PubMed ID: 11397776
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.